CD56 expression in acute myeloid leukemia (AML) has been associated with
extramedullary leukemia and multidrug resistance, but its clinical and prognostic …

CD56, a neural cell-adhesion molecule, is expressed in normal NK cells, so the antigen is a
good marker for identifying malignancies in NK cell lineages. 1 CD56 is aberrantly …

We established a factor-independent acute myeloid leukemia cell line, designated Ei501.
The line has been growing in RPMI 1640 media for 18 months and can be maintained …

Aberrant antigen expression in acute myeloid leukemia (AML) has been extensively studied
in the West with limited reports from Taiwan. We carried out this retrospective study to …

A 30-year-old woman was admitted to our department in June 2002 with a history of 4 weeks
of infection (cold), fever (391C) and tiredness. Physical examination of the young woman …

We report a case of acute myeloid leukemia which we have classified as acute
megakaryoblastic leukemia because of intracytoplasmic expression of CD61. Light …

The prognostic significance of immunophenotypical properties of leukaemic cells is well
known. However, the biological and clinical significance of CD7 and CD56 antigen …

From a cohort of 220 adults with newly diagnosed acute myeloid leukemia (AML), 8 (3.6%)
exhibited a rare variant of aberrant membrane phenotype. It was characterized with typical …

The aims of this study were to investigate the frequency and prognostic relevance of CD56
expression in patients with acute myeloid leukemia (AML) and to compare the importance of …

Abstract CD56 antigen, a 200–220 kDa cell surface glycoprotein, identified as an isoform of
the neural adhesion molecules (NCAM), has been found frequently expressed in several …